CNS Pharmaceuticals, Inc. (CNSP)
Data as of , from SEC Form 4 filings.
See up to 3 months of CNSP. The 7-day demo opens the 1M and 3M ranges and puts CNSP on your watchlist.
Start 7-day demoLatest CNSP insider trades
- Michal Fisher - DirectorOpen-market purchase$10K
- Faith L. Charles - DirectorOpen-market purchase$34K
Rami Levin - Officer
About CNS Pharmaceuticals, Inc. (CNSP)
CNS Pharmaceuticals, Inc. files with the SEC under CIK 0001729427 and is classified as pharmaceutical preparations. It is grouped with Health Care companies on this site.
CNSP Form 4 activity by transaction type, last 90 days
| Form 4 transaction type | Transactions | Shares | Total value |
|---|---|---|---|
| Open-market purchase | 1 | 2,000 | $10K |
| Option exercise | 2 | 9,500 |
Dollar totals cover purchases and sales only (codes P and S). Grants, option exercises, gifts and tax withholding are counted in shares, because none of them is a trade at a market price.
CNSP insider transactions (Form 4)
1413 Form 4 filings on record, the earliest from Nov 19, 2025, newest first.
| Date | Insider | Transaction | Security | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Michal Fisher - Director | Open-market purchase | Common Stock | 2,000 | $5.00 | $10K | |
| Rami Levin - Officer | Option exercise | Common Stock | 4,750 | $0.00 | - | |
| Rami Levin - Officer | Option exercise | Restricted Stock Units | 4,750 | $0.00 footnote F3 | - | |
| ||||||
| Faith L. Charles - Director | Open-market purchase | Common Stock | 7,100 | $4.79 | $34K | |
| Eric Faulkner - Officer | Grant or award | Restricted Stock Units | 9,500 | - footnote F3 | - | |
| ||||||
| Steve O'Loughlin - Officer | Grant or award | Restricted Stock Units | 9,500 | - footnote F3 | - | |
| ||||||
| Rami Levin - Officer | Grant or award | Restricted Stock Units | 19,000 | - | - | |
| Bettina M. Cockroft - Director | Grant or award | Option to purchase common stock | 1,517 | $0.00 footnote F3 | - | |
| ||||||
| Amy Mahery - Director | Grant or award | Option to purchase common stock | 1,517 | $0.00 footnote F3 | - | |
| ||||||
| Faith L. Charles - Director | Grant or award | Option to purchase common stock | 1,517 | $0.00 footnote F3 | - | |
| ||||||
| Jerzy Gumulka - Director | Grant or award | Option to purchase common stock | 1,517 | $0.00 footnote F3 | - | |
| ||||||
| Christopher Downs - Officer | Grant or award | Option to purchase common stock | 4,881 | $0.00 footnote F3 | - | |
| ||||||
| Jeffry R. Keyes - Director | Grant or award | Option to purchase common stock | 1,517 | $0.00 footnote F3 | - | |
| ||||||
| John M. Climaco - Officer | Grant or award | Option to purchase common stock | 9,761 | $0.00 footnote F3 | - | |
| ||||||
CNSP insider trading FAQ
What is the latest insider trade for CNSP?
CNS Pharmaceuticals, Inc. (CNSP) had 2 insider filings in the last 90 days, with the most recent on 2026-08-18. The full record for CNSP runs to 13 Form 4 filings, the earliest from 2025-11-19. InsiderAlpha adds new Form 4, Form 144 and 8-K filings as they arrive from SEC EDGAR.
How many insiders are buying CNSP stock?
1 insider purchase of CNSP was filed in the last 90 days, totaling $10K.
How many insiders are selling CNSP stock?
No insider sales of CNSP were filed in the last 90 days.
Where can I see CNSP SEC filings (Form 4, 10-K, 10-Q, 8-K)?
This page collects CNSP Form 4 insider transactions, Form 144 sale notices and 8-K filings in one place. Annual 10-K and quarterly 10-Q reports live on the company's SEC EDGAR page.
More Health Care companies with insider activity
Recent insider filings
10The EDGAR links open each original Form 4, so you can check any number on this page against the filing it came from.
- - Michal Fisher view on EDGAR
- - Rami Levin view on EDGAR
- - Faith L. Charles view on EDGAR
- - Eric Faulkner view on EDGAR
- - Steve O'Loughlin view on EDGAR
- - Rami Levin view on EDGAR
- - Bettina M. Cockroft view on EDGAR
- - Amy Mahery view on EDGAR
- - Faith L. Charles view on EDGAR
Related companies with recent insider activity
Learn more
- How to read insider buying signals
- What an open-market purchase by an insider can and cannot tell you.
- Insider activity in Health Care
- Where CNSP's peers are being bought and sold.
- Every recent Form 4
- The market-wide feed, updated as filings arrive from SEC EDGAR.
Follow CNSP with a 7-day demo
- CNSP on your watchlist
- Every CNSP Form 4 filing on record
- Up to 3 months of CNSP price history
- The daily trading plan of ranked insider buys, on a delay, with the plan archive
